55 results
8-K
EX-4.1
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
market prices) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
8-K
EX-10.1
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
(a), and the Company and each Investor shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants
8-K
CRVS
Corvus Pharmaceuticals Inc
6 May 24
Entry into a Material Definitive Agreement
4:11pm
, subject to the satisfaction of customary closing conditions. The Pre-Funded Warrants and Common Warrants are not listed on the Nasdaq Global Market … conditions, the satisfaction of customary closing conditions relating to the Offering, and the other important factors discussed under the caption “Risk
8-K
EX-4.2
k9tqj95s073nwbny
6 May 24
Entry into a Material Definitive Agreement
4:11pm
424B5
xr6w1i7s
3 May 24
Prospectus supplement for primary offering
4:05pm
8-K
EX-1.1
jek2 b34bp
2 Nov 21
Entry into a Material Definitive Agreement
6:10am
424B5
49kws e6zkivsazwak8j
2 Nov 21
Prospectus supplement for primary offering
6:05am